
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| DAWNZERA (AUTOINJECTOR) | Ionis Pharmaceuticals | N-219407 RX | 2025-08-21 | 1 products, RLD, RS |
Brand Name | Status | Last Update |
|---|---|---|
| dawnzera | New Drug Application | 2025-09-24 |

Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hereditary angioedemas | D054179 | EFO_0004131 | — | — | 2 | 2 | — | 1 | 5 |
| Angioedema | D000799 | EFO_0005532 | T78.3 | — | 2 | 2 | — | 1 | 5 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 1 | — | — | — | — | 1 |
| Drug common name | Donidalorsen |
| INN | donidalorsen |
| Description | Donidalorsen is an oligonucleotide pharmaceutical. It is currently being investigated in clinical studies. |
| Classification | Oligonucleotide |
| Drug class | antisense oligonucleotides |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | — |
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | CHEMBL4650235 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | ZD4D8M32TL (ChemIDplus, GSRS) |
